Left main coronary artery compression in pulmonary hypertension.
Jonathan E LabinRajan SaggarEric H YangGentian LluriDavid SayahRichard ChannickAbbas ArdehaliOlcay AksoyRushi V ParikhPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Extrinsic compression of the left main coronary artery (LMCA) by a dilated pulmonary artery (PA) in the setting of pulmonary arterial hypertension (PAH) is an increasingly recognized disease entity. LMCA compression has been associated with angina, arrhythmia, heart failure, and sudden cardiac death in patients with PAH. Recent studies suggest that at least 6% of patients with PAH have significant LMCA compression. Screening for LMCA compression can be achieved with computed coronary tomography angiography, with a particular emphasis on assessment of PA size and any associated downward displacement and reduced takeoff angle of the LMCA. Indeed, evidence of a dilated PA (>40 mm), a reduced LMCA takeoff angle (<60°), and/or LMCA stenosis on CCTA imaging should prompt further diagnostic evaluation. Coronary angiography in conjunction with intravascular imaging has proven effective in diagnosing LMCA compression and guiding subsequent treatment. While optimal medical therapy and surgical correction remain in the clinician's arsenal, percutaneous coronary intervention has emerged as an effective treatment for LMCA compression. Given the prevalence of LMCA compression, its associated morbidity, and mortality, and the wide array of successful treatment strategies, maintaining a high degree of suspicion for this condition, and understanding the potential treatment strategies is critical.
Keyphrases
- coronary artery
- pulmonary artery
- pulmonary arterial hypertension
- pulmonary hypertension
- high resolution
- heart failure
- percutaneous coronary intervention
- coronary artery disease
- healthcare
- computed tomography
- acute coronary syndrome
- acute myocardial infarction
- optical coherence tomography
- stem cells
- risk factors
- bone marrow
- combination therapy
- antiplatelet therapy
- replacement therapy
- magnetic resonance
- polycyclic aromatic hydrocarbons
- atrial fibrillation
- fluorescence imaging
- contrast enhanced
- acute heart failure
- transcatheter aortic valve replacement